Hence, pharmacological EZH2 inhibition using the EZH2 specific inhibitors UNC1999 and GSK343 induced anti-MM effects by reactivating genes involved in differentiation, cell cycle and apoptosis. This evidence concerns the gene EZH2 and Miyoshi myopathy.